Activation capacity of the alternative and classic complement pathways in patients operated on for colorectal cancer

Diseases of the Colon and Rectum

Volumn 45, Issue 4, 2002, Pages 544-553

  Zimmermann Nielsen, Erik ^a   Iversen, Lene H ^b   Svehag, Sven Erik ^c   Thorlacius Ussing, Ole ^a   Baatrup, Gunnar ^d  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b LILLEBAELT HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Funen Hospital   (Denmark)

Author keywords

Alternative; C3b analysis; Classic; Colorectal cancer; Complement pathways; Surgery

Indexed keywords

COMPLEMENT COMPONENT C3;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; COLORECTAL SURGERY; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; THROMBOEMBOLISM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COMPLEMENT ACTIVATION; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0036110792     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6237-6     Document Type: Article

References (25)

1. Advances in immunology: Complement: First of two parts
2. Primary immunodeficiency diseases
3. Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3b
4. Immune complexes in solid tumors precipitable by 3.5% polyethylene glycol: Analysis of some nonspecific components
5. Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium
6. Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer
7. Expression and function of CD59 on colonic adenocarcinoma cells
8. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells
9. Perioperative functional activity of the alternative pathway of complement in patients with colonic cancer
10. Estimation of serum complement and its role in management of trauma
11. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery
12. Do operations facilitate tumor growth? An experimental model in rats
13. Possible induction of blood transfusion of immunological tolerance against growth of transplanted tumors in mice
14. Complement activation and organ function in critically ill surgical patients
15. Complement activation in vitro induced by endotoxin and injured tissue
16. ELISA for incorporation of plasma derived complement split-products C3b/iC3b into solid-phase immune complexes
17. Comparative study of assays detecting complement activation: Complement split-product C3d (rocket immuno-electrophoresis) and C3d neodeterminants (ELISA)
18. Complement in the pathophysiology and diagnosis of human diseases
19. Clinical utility of complement assessment
20. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): Binding of complement and C-reactive protein by IL-2-activated lymphocytes
21. Activity and activation of the complement system in patients being operated on for cancer of the colon
22. Randomised comparison of leucocyte-depleted versus buffy-coat poor blood transfusion and complications after colorectal surgery
23. Perioperative blood transfusions and outcome after resection for colorectal carcinoma
24. Prevention of venous thromboembolism: International consensus statement
25. Interrelationships between the immune systems, complement, coagulation, and inflammation